The Discounted Cash Flow (DCF) valuation of Heron Therapeutics Inc (HRTX) is (3.33) USD. With the latest stock price at 2.14 USD, the upside of Heron Therapeutics Inc based on DCF is -255.8%.
Based on the latest price of 2.14 USD and our DCF valuation, Heron Therapeutics Inc (HRTX) is a sell. selling HRTX stocks now will result in a potential gain of 255.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.3% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (7.82) - (2.41) | (3.33) |
| Upside | -465.5% - -212.4% | -255.8% |